Corvert

Active Ingredient(s): Ibutilide
FDA Approved: * December 28, 1995
Pharm Company: * PHARMACIA AND UPJOHN
Category: Irregular Heartbeat (Arrhythmia)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Corvert Overview

Ibutilide is a Class III antiarrhythmic agent that is indicated for acute cardioconversion of atrial fibrillation and atrial flutter of a recent onset to sinus rhythm. It exerts its antiarrhythmic effect by induction of slow inward sodium current, which prolongs action potential and refractory period (physiology) of myocardial cells. Because of its Class III antiarrhythmic activity, there should not be concomitant administration of Class Ia and Class III agents. Ibutilide is marketed as Corve...

Read more Corvert Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ibutilide

Recent Corvert Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ibutilide
  • Injection: 0.1mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Corvert: (1 result)

Sorted by National Drug Code
  • 0009-3794 Corvert .1 mg/ml Intravenous Injection, Solution by Pharmacia and Upjohn Company

Other drugs which contain Ibutilide or a similar ingredient: (1 result)